2016 Epilepsy Pipeline Conference
Event: Presentation by Christopher U. Missling, PhD, President and Chief Executive Officer Date/Time: Friday, February 26, 2016 Location: Grand Hyatt San Francisco
Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) Forum 2016
Event: Poster Presentation by Robert Lisak, M.D., Professor of Neurology at Wayne State University School of Medicine (lead investigator of study) Date/Time: Thursday, February 19, 2016 12:30 p.m. CT Location: Hyatt Regency New Orleans, Storyville Hall, New Orleans, Louisiana
18th Annual BIO CEO & Investor Conference
Event: Presentation by Christopher U. Missling, PhD, President and Chief Executive Officer Date/Time: Tuesday, February 9, 2016 1:30 p.m. ET Location: Conrad Suite, 4th Floor, The Waldorf-Astoria Hotel, New York, NY
American Epilepsy Society Annual Meeting
Event: Novel Anti-Seizure Compound ANAVEX 2-73 a Sigma-1 Receptor Agonist in Multiple Seizure Models Date/Time: Monday, December 7, 2015 8:00 a.m. – 2:00 p.m. Location: Pennsylvania Convention Center, Hall A, 200 Level, Philadelphia, PA
Third Annual MHPAEA Business Roundtable
Event: Alzheimer’s case study (Anavex pipeline) by Christopher U. Missling, PhD, President and Chief Executive Officer Date/Time: Tuesday, December 8, 2015 Location: U.S. Capitol Visitor Center, Washington, D.C.
ICV Manhattan 2015
Event: Corporate Overview by Christopher U. Missling, PhD, President and Chief Executive Officer Date/Time: Wednesday, December 9, 2015 9:10 a.m. ET Location: Mandarin Oriental, 36th Floor, 80 Columbus Circle Drive, New York, NY